2 results
Approved WMOPending
PrimaryTo demonstrate the superiority of galcanezumab versus placebo in the prevention of migraine in an adolescent population (12 to 17 year-olds) with chronic migraineSecondary* To compare galcanezumab with placebo with respect to 50% response…
Approved WMOCompleted
The aim of this study is to see if the Snoozeal device is as effective as the previous methods and if it can reduce snoring and improve sleep quality.